Top Markets
#1 DogBull DogBull +106.54%
#2 ADO Protocol ADO Protocol +51.13%
#3 Siacoin Siacoin +44.31%
#4 The Bitcoin Bull The Bitcoin Bull +41.91%
#5 MarsCoin MarsCoin +31.39%
#6 Ontology Gas Ontology Gas +28.06%
#7 Glidr Glidr +26.45%
#8 UnifAI Network UnifAI Network +24.47%
#9 Falcon Finance Falcon Finance +17.55%
#10 Nockchain Nockchain +15.28%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Zhejiang Xinguang Pharmaceutical Co., Ltd. Zhejiang Xinguang Pharmaceutical Co., Ltd.

Zhejiang Xinguang Pharmaceutical Co., Ltd.

300519
Rank in Stocks #15627
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and... Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.
Share Price
$2.13
Market Cap
$341.30M
Change (1 day)
1.66%
Change (1 year)
-8.53%
Country
CN
Trade Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519)

Category

Healthcare
Revenue for Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519)
Revenue in Sep 2026 TTM: 0
According to Zhejiang Xinguang Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zhejiang Xinguang Pharmaceutical Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US